The pharmaceutical industry is one of the leading
industries in India, and is soon becoming one of the most advanced countries
of the world in terms of the growth of the health sector and advancements in
pharmaceutical equipments and production of bulk pharmaceutical drugs.
Covering many aspects of the industry, the EXIM policy is also prepared
keeping in mind the interest of the pharmaceutical machines and drugs
manufacturers and the Govt. of India. The government is looking at exim
policy options to further grow the country's thriving pharmaceutical
industry and check growing examples of takeovers by foreign players.
The import and export of pharmaceutical drugs and pharmaceuticals are
regulated through EXIM Policy. India is now globally considered as one of
the leading global players in pharmaceuticals. Europe occupies the highest
share of Indian pharma exports followed by North America and Asia. The
pharma EXIM policy initiatives taken by the Government recently have led to
quantitative and qualitative improvements in the Research & Development
activities of the industry. The National Pharmaceutical Policy (NPP)'s
objective is to ensure availability of lifesaving drugs at reasonable
prices.
For a more clear idea of the export and import policy of the Indian
pharmaceutical industry, check out the following: